Alpha Cognition Inc (ACOG)

Currency in USD
5.80
+0.05(+0.87%)
Closed·
5.79-0.01(-0.17%)
·
ACOG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.655.92
52 wk Range
4.5011.54
Key Statistics
Prev. Close
5.8
Open
5.76
Day's Range
5.65-5.92
52 wk Range
4.5-11.54
Volume
15.65K
Average Volume (3m)
57.91K
1-Year Change
-45.1537%
Book Value / Share
2.64
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACOG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.00
Upside
+175.86%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Alpha Cognition Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.00
(+175.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy14.00+141.38%-New Coverage17/04/2026
H.C. Wainwright
Buy18.00+210.34%-Maintain24/11/2025
H.C. Wainwright
Buy18.00+210.34%20.00Maintain21/10/2025
H.C. Wainwright
Buy20.00+244.83%-Maintain03/07/2025

Alpha Cognition Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue surged 40% quarter-over-quarter to $3.5M, driven by ZUNVEYL Alzheimer's treatment commercialization and 23% rise in bottles dispensed.
  • Net loss widened to $6.5M from $1.7M year-over-year as operating expenses climbed 8.4% to $11.6M, reflecting investments in commercial infrastructure.
  • Company maintains debt-free balance sheet with $54.2M cash position; full-year 2026 operating expense guidance held at $54M-$58M range.
  • Management targets operating profitability by 2027; analysts project 123% revenue growth for fiscal 2026 but anticipate continued losses near-term.
  • Stock trades at $5.95 with $129.55M market cap, appearing undervalued versus analyst price targets of $14-$18 per share.
Last Updated: 14/05/2026, 22:18
Read Full Transcript

Earnings

Latest Release
26/03/2026
EPS / Forecast
-0.30 / -0.77
Revenue / Forecast
2.79M / --
EPS Revisions
Last 90 days

Compare ACOG to Peers and Sector

Metrics to compare
ACOG
Peers
Sector
Relationship
P/E Ratio
−5.0x−3.6x−0.5x
PEG Ratio
0.33−0.100.00
Price/Book
2.2x2.6x2.6x
Price / LTM Sales
11.7x6.9x3.1x
Upside (Analyst Target)
175.9%336.8%55.1%
Fair Value Upside
Unlock12.8%7.2%Unlock

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer’s disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.

Employees
71

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
11.99K0.06%68.95K
Other Institutional Investors
16.34M75.06%93.98M
Public Companies & Retail Investors
5.42M24.88%31.15M
Total
21.77M100.00%125.2M

People Also Watch

1.30
NPT
-4.41%
5.9300
HTCO
-3.89%
7.01
BRAI
-3.31%
5.9300
AZ
-4.82%

FAQ

What Is the Alpha Cognition (NASDAQ: ACOG) Share Price Today?

The Alpha Cognition stock price today is 5.80 USD.

What Stock Exchange Does Alpha Cognition (ACOG) Trade On?

Alpha Cognition is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Alpha Cognition?

The stock symbol (also called a 'ticker') for Alpha Cognition is "ACOG."

What Is the Current Alpha Cognition Market Capitalisation?

As of today, Alpha Cognition (NASDAQ: ACOG) market cap is 126.29M USD.

What Is Alpha Cognition's (ACOG) Earnings Per Share (TTM)?

The Alpha Cognition EPS is currently -1.37 (Trailing Twelve Months).

Is ACOG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Alpha Cognition moving averages and other technical indicators, the daily buy/sell signal for ACOG stock is Strong Sell.

How Many Times Has Alpha Cognition Stock Split?

Alpha Cognition has split 1 times. (See the ACOG stock split history page for full effective split date and price information.)

How Many Employees Does Alpha Cognition Have?

Alpha Cognition has 71 employees, based on their latest Companies House report.

What is the current trading status of Alpha Cognition (NASDAQ: ACOG)?

As of 20/05/2026, Alpha Cognition (ACOG) is trading at a share price of 5.80 USD, with a previous close of 5.80 USD. The stock has fluctuated within a day range of 5.65 USD to 5.92 USD, while its 52-week range spans from 4.50 USD to 11.54 USD.

What Is Alpha Cognition (ACOG) Price Target According to Analysts?

The average 12-month price target for Alpha Cognition is 16.00 USD, with a high estimate of 18 USD and a low estimate of 14 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +175.86% Upside potential.

What Is the ACOG After Hours Price?

ACOG's last after hours stock price is 5.79 USD, the stock has decreased by -0.01, or -0.17%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.